Ownership history in MORGAN STANLEY · 42 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in DIREXION SHS ETF TR (CURE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1 | -455 | -99.8% | 0.00% | $123 | $83.31 |
| 2025 Q2 | ADDED | 456 | +244 | +115.1% | 0.00% | $36K | $78.31 |
| 2025 Q1 | REDUCED | 212 | -709 | -77.0% | 0.00% | $23K | $105.49 |
| 2024 Q4 | ADDED | 921 | +334 | +56.9% | 0.00% | $85K | $91.03 |
| 2024 Q3 | ADDED | 587 | +583 | +14575.0% | 0.00% | $78K | $131.20 |
| 2024 Q2 | ADDED | 4 | +3 | +300.0% | 0.00% | $509 | $114.79 |
| 2024 Q1 | REDUCED | 1 | -509 | -99.8% | 0.00% | $128 | $123.00 |
| 2023 Q4 | ADDED | 510 | +357 | +233.3% | 0.00% | $52K | $99.46 |
| 2023 Q3 | REDUCED | 153 | -278 | -64.5% | 0.00% | $14K | $86.02 |
| 2023 Q2 | REDUCED | 431 | -72 | -14.3% | 0.00% | $43K | $96.71 |
As of 2025 Q4 — sorted by position size